Abstract:The immunoregulatory effects of TCGF (T-cell growth factor) on the generation and growth of syngeneic murine malignant glioma (20-methylcholanthrene-induced 203-glioma)-specific killer T-cell were investigated in C57BL/6 adult mice in order to clarify the immunopotential usefulness for anti-tumor local adoptive immunotherapy against malignant brain tumor. TCGF was prepared and assayed. Briefly, 5 x 10(6) ml mouse spleen cells were cultured with 2 microgram/ml concanavalin A in RPMI-1640 medium supplemented with 2% fetal calf serum for 24 hours. Culture supernatants were concentrated by ammonium sulphate precipitation (55 to 80% saturation) and purified by gel filtration (Sephadex G-100, a molecular weight from 30 to 36,000 daltons) and ion exchange chromatography (DEAE-cellulose, elution with 0.15 M in NaCl at ph 7.4). The purified TCGF had no IFN activity. Assays for TCGF was performed for quantitative analysis using 203-glioma-specific killer T cell clone (G-CTLL), which was obtained by limiting dilution method (0.3 cells/well in 96 well microtiter plate) and maintained for over 6 months in the presence of TCGF. Titer (U/ml) of TCGF was defined as the quantity of TCGF required to obtain one-half of the maximal stimulation of G-CTLL proliferation assay. It was confirmed that the specific killer T-cell against 203-glioma was generated in mice after intracranial as well as subcutaneous inoculation of the tumor cells. The killer T-cell activity of spleen cells, however, began to be severely impaired 2 weeks after intracranial inoculation concurrently with the increased intracranial pressure due to developing the tumor growth. Sensitized lymphocytes obtained from intracranial and subcutaneous tumor-bearing mice were assessed for CTL (cytotoxic T-lymphocyte) activity in MLTC (mixed lymphocyte-tumor cell culture) for 18 hours by microcytotoxicity assay. The specific cytotoxicity against 203-glioma cells was enhanced when sensitized lymphocytes from intracranial and subcutaneous tumor-bearing mice were pre-cultured with optimal TCGF (20 U/ml) for over 5 days. After the treatment of sensitized lymphocytes with anti-Thy-1 monoclonal antibody and complement, however, the specific cytotoxicity of sensitized lymphocytes was eliminated almost completely. Therefore, it was thought that TCGF possesses immunoregulatory effects of enhancement of killer T-cell activity. On the contrary, TCGF had no influence on normal T lymphocytes and the growth of 203-glioma cells in vitro.(ABSTRACT TRUNCATED AT 400 WORDS)

Partial purification and biochemical characterization of a T cell suppressor factor produced by human glioblastoma cells.

[Preparation and Characterization of Monoclonal Antibody Against Human Telomeric Repeat Binding Factor 1].

S100B Suppression Alters Polarization of Infiltrating Myeloid-Derived Cells in Gliomas and Inhibits Tumor Growth.

A Preliminary Study on Tumor-Derived Immunosuppressive Factors

[Effects of TCGF (T-cell growth factor) on experimental malignant glioma-specific killer T-cell]

[Purification of Fusion Protein HSA/IL1ra and Its Bioactivity].

Characterization and purification of a macrophage-triggering factor produced in Mycoplasma arginini-infected L5178Y cell cultures.

cDNA clone, prokaryotic expression and purification of human interleukin-13 receptor [alpha]2 chain

Comparison of Four Methods for the Purification and Refolding of Human Interleukin‐2–mouse Granulocyte/macrophage Colony‐stimulating Factor Fusion Protein

Production of Extracellular Domain of Human Tissue Factor Using Maltose-Binding Protein Fusion System.

Isolation and Purification of GFLP, a High-molecule Polysaccharide from Grifola frondosa Fruit Bodies,and its Effect on Immune Cells

CHARACTERIZATION OF AN ANTIGEN‐SPECIFIC FACTOR FROM A HYBRID T‐CELL LINE *

Purification and Identification of Recombinant Human Granulocyte Colony-Stimulating Factor Muteint (Rhg-Csf-ala-17)

BIOM-31. TEMPOROSPATIAL PROTEIN PROFILING OF HUMAN GLIOBLASTOMAS REVEALS MOLECULAR MECHANISMS AND BIOMARKERS UNDERLYING RESPONSES TO IMMUNE CHECKPOINT INHIBITION

Purification, Characterization and in Vitro Anti-Tumor Activity of Proteins from Arca Subcrenata Lischke

Purification of a cell growth factor from a human lung cancer cell line: Its relationship with ferritin

Purification Of Recombinant Gm-Csf/Il-3 Fusion Protein

Molecular-Cloning And Functional Expression Of A Cdna-Encoding Glycosylation-Inhibiting Factor

Purification and Biologic Characterization of Soluble Tumor Necrosis Factor Receptor

Tissue Factor Expression and Angiogenesis in Human Glioma

Immu-20. Circulating Cell-Free Dna Directly Inhibits T Cell Responses And Contributes To Systemic Immunosuppression In Glioblastoma